American Portfolios Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $327K | Sell |
1,661
-34
| -2% | -$6.69K | 0.01% | 816 |
|
|
2022
Q2 | $363K | Sell |
1,695
-1,132
| -40% | -$242K | 0.01% | 800 |
|
|
2022
Q1 | $803K | Sell |
2,827
-666
| -19% | -$189K | 0.03% | 559 |
|
|
2021
Q4 | $1.32M | Buy |
3,493
+335
| +11% | +$126K | 0.04% | 399 |
|
|
2021
Q3 | $1.3M | Sell |
3,158
-94
| -3% | -$38.8K | 0.05% | 363 |
|
|
2021
Q2 | $1.2M | Buy |
3,252
+167
| +5% | +$61.8K | 0.05% | 389 |
|
|
2021
Q1 | $894K | Buy |
3,085
+386
| +14% | +$112K | 0.04% | 441 |
|
|
2020
Q4 | $674K | Buy |
2,699
+154
| +6% | +$38.5K | 0.03% | 465 |
|
|
2020
Q3 | $576K | Buy |
2,545
+9
| +0.4% | +$2.04K | 0.03% | 438 |
|
|
2020
Q2 | $442K | Buy |
2,536
+1,170
| +86% | +$204K | 0.03% | 471 |
|
|
2020
Q1 | $172K | Sell |
1,366
-231
| -14% | -$29.2K | 0.01% | 699 |
|
|
2019
Q4 | $244K | Buy |
1,597
+76
| +5% | +$11.6K | 0.02% | 674 |
|
|
2019
Q3 | $201K | Buy |
1,521
+48
| +3% | +$6.35K | 0.02% | 714 |
|
|
2019
Q2 | $209K | Buy |
1,473
+36
| +3% | +$5.11K | 0.02% | 700 |
|
|
2019
Q1 | $209K | Buy |
1,437
+87
| +6% | +$12.6K | 0.02% | 626 |
|
|
2018
Q4 | $153K | Sell |
1,350
-77
| -5% | -$8.72K | 0.02% | 599 |
|
|
2018
Q3 | $192K | Hold |
1,427
| – | – | 0.02% | 596 |
|
|
2018
Q2 | $160K | Sell |
1,427
-16
| -1% | -$1.8K | 0.02% | 642 |
|
|
2018
Q1 | $154K | Buy |
1,443
+129
| +10% | +$13.8K | 0.02% | 614 |
|
|
2017
Q4 | $144K | Buy |
+1,314
| New | +$144K | 0.02% | 618 |
|